Last reviewed · How we verify

NCT06147024

Utilizing 3D Printed Personalized Aortic Lesion Models in Preoperative Assessment

Recruiting now NA Last updated 27 February 2026
What this trial tests

NA trial testing historical control in Aortic Aneurysm in 10 participants. Currently enrolling.

Timeline
8 April 2024
Primary endpoint
31 July 2027
31 July 2027

Quick facts

Lead sponsorFu Jen Catholic University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposeother
Enrollment10
Start date8 April 2024
Primary completion31 July 2027
Estimated completion31 July 2027
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Fu Jen Catholic University

Who can join

Adults 18 to 80, any sex, with Aortic Aneurysm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Using 3D printing technology to create personalized models of diseased heart and aortic blood vessels, surgeons can perform preoperative planning and evaluate relevant indicators.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Next-generation epidermal patches: Bridging 3D and multidimensional printing for biomedical and personal care innovations.
    El-Khordagui LK, El-Habashy SE, Simchi A, Tohamy HS, et al · · 2026 · PMID 42005999 · DOI 10.1016/j.bioactmat.2026.03.054

Verify or expand the search:

Other recruiting trials for Aortic Aneurysm

Currently open trials in the same condition.

Other Fu Jen Catholic University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06147024.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing